Literature DB >> 2506646

The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias.

G Gallo1, M Picken, J Buxbaum, B Frangione.   

Abstract

Immunocytic dyscrasias may be manifested by MIDD often presenting with renal manifestations. The diagnosis is established when deposits are shown by immunopathologic methods to contain a single light-chain isotype in patients who have a monoclonal Ig in the serum or urine, altered kappa:lambda ratio in bone marrow, and/or abnormal biosynthesis of Igs in bone marrow cell cultures. The morphologic expressions of deposits are varied: fibrillar in AL, granular and punctate in LCDD, granular or crystalline in LHCDD, and crystalline in type I cryoglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506646

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  11 in total

1.  Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.

Authors:  R Vidal; F Goñi; F Stevens; P Aucouturier; A Kumar; B Frangione; J Ghiso; G Gallo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.

Authors:  A A Khamlichi; P Aucouturier; C Silvain; M Bauwens; G Touchard; J L Preud'homme; F Nau; M Cogné
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

3.  The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA.

Authors:  Xiaoyun Meng; Anthony L Fink; Vladimir N Uversky
Journal:  J Mol Biol       Date:  2008-06-28       Impact factor: 5.469

4.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 5.  Molecular anatomy and the pathological expression of antibody light chains.

Authors:  M Schiffer
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  A role for destabilizing amino acid replacements in light-chain amyloidosis.

Authors:  M R Hurle; L R Helms; L Li; W Chan; R Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Potential role of apolipoprotein-E in fibrillogenesis.

Authors:  G Gallo; T Wisniewski; N H Choi-Miura; J Ghiso; B Frangione
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

8.  AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences.

Authors:  Kip Bodi; Tatiana Prokaeva; Brian Spencer; Maurya Eberhard; Lawreen H Connors; David C Seldin
Journal:  Amyloid       Date:  2009-03       Impact factor: 7.141

9.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.

Authors:  G Gallo; F Goñi; F Boctor; R Vidal; A Kumar; F J Stevens; B Frangione; J Ghiso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

10.  Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN.

Authors:  Dongmei Hu; Zhijie Qin; Bin Xue; Anthony L Fink; Vladimir N Uversky
Journal:  Biochemistry       Date:  2008-07-25       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.